Logo image of MYRG

MYR GROUP INC/DELAWARE (MYRG) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MYRG - US55405W1045 - Common Stock

228.54 USD
-1.69 (-0.73%)
Last: 12/5/2025, 8:00:01 PM
228.54 USD
0 (0%)
After Hours: 12/5/2025, 8:00:01 PM
Fundamental Rating

5

Overall MYRG gets a fundamental rating of 5 out of 10. We evaluated MYRG against 55 industry peers in the Construction & Engineering industry. While MYRG has a great health rating, its profitability is only average at the moment. MYRG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year MYRG was profitable.
MYRG had a positive operating cash flow in the past year.
MYRG had positive earnings in each of the past 5 years.
In the past 5 years MYRG always reported a positive cash flow from operatings.
MYRG Yearly Net Income VS EBIT VS OCF VS FCFMYRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.95%, MYRG is in the better half of the industry, outperforming 61.82% of the companies in the same industry.
MYRG's Return On Equity of 15.84% is fine compared to the rest of the industry. MYRG outperforms 63.64% of its industry peers.
The Return On Invested Capital of MYRG (11.85%) is better than 69.09% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MYRG is significantly below the industry average of 17.90%.
The last Return On Invested Capital (11.85%) for MYRG is above the 3 year average (8.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.95%
ROE 15.84%
ROIC 11.85%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
MYRG Yearly ROA, ROE, ROICMYRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 2.78%, MYRG is in line with its industry, outperforming 47.27% of the companies in the same industry.
MYRG's Profit Margin has declined in the last couple of years.
MYRG's Operating Margin of 4.13% is in line compared to the rest of the industry. MYRG outperforms 41.82% of its industry peers.
MYRG's Operating Margin has declined in the last couple of years.
MYRG has a Gross Margin of 11.34%. This is in the lower half of the industry: MYRG underperforms 70.91% of its industry peers.
In the last couple of years the Gross Margin of MYRG has declined.
Industry RankSector Rank
OM 4.13%
PM (TTM) 2.78%
GM 11.34%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
MYRG Yearly Profit, Operating, Gross MarginsMYRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MYRG is still creating some value.
MYRG has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MYRG has been reduced compared to 5 years ago.
The debt/assets ratio for MYRG is higher compared to a year ago.
MYRG Yearly Shares OutstandingMYRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MYRG Yearly Total Debt VS Total AssetsMYRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 5.09 indicates that MYRG is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 5.09, MYRG is doing good in the industry, outperforming 78.18% of the companies in the same industry.
MYRG has a debt to FCF ratio of 0.48. This is a very positive value and a sign of high solvency as it would only need 0.48 years to pay back of all of its debts.
MYRG's Debt to FCF ratio of 0.48 is amongst the best of the industry. MYRG outperforms 89.09% of its industry peers.
MYRG has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.11, MYRG belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.48
Altman-Z 5.09
ROIC/WACC1.17
WACC10.13%
MYRG Yearly LT Debt VS Equity VS FCFMYRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

MYRG has a Current Ratio of 1.33. This is a normal value and indicates that MYRG is financially healthy and should not expect problems in meeting its short term obligations.
MYRG has a Current ratio (1.33) which is in line with its industry peers.
A Quick Ratio of 1.33 indicates that MYRG should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.33, MYRG is in the better half of the industry, outperforming 61.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.33
MYRG Yearly Current Assets VS Current LiabilitesMYRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 170.31% over the past year.
Measured over the past years, MYRG shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.84% on average per year.
Looking at the last year, MYRG shows a decrease in Revenue. The Revenue has decreased by -0.64% in the last year.
MYRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.17% yearly.
EPS 1Y (TTM)170.31%
EPS 3Y-28.02%
EPS 5Y-3.84%
EPS Q2Q%215.38%
Revenue 1Y (TTM)-0.64%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%7.02%

3.2 Future

The Earnings Per Share is expected to grow by 57.07% on average over the next years. This is a very strong growth
Based on estimates for the next years, MYRG will show a small growth in Revenue. The Revenue will grow by 7.77% on average per year.
EPS Next Y287.83%
EPS Next 2Y121.01%
EPS Next 3Y76.65%
EPS Next 5Y57.07%
Revenue Next Year4.73%
Revenue Next 2Y7.17%
Revenue Next 3Y7.11%
Revenue Next 5Y7.77%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MYRG Yearly Revenue VS EstimatesMYRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
MYRG Yearly EPS VS EstimatesMYRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

MYRG is valuated quite expensively with a Price/Earnings ratio of 36.92.
MYRG's Price/Earnings is on the same level as the industry average.
MYRG's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.49.
Based on the Price/Forward Earnings ratio of 25.29, the valuation of MYRG can be described as expensive.
65.45% of the companies in the same industry are more expensive than MYRG, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.69. MYRG is around the same levels.
Industry RankSector Rank
PE 36.92
Fwd PE 25.29
MYRG Price Earnings VS Forward Price EarningsMYRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MYRG indicates a somewhat cheap valuation: MYRG is cheaper than 63.64% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, MYRG is valued a bit cheaper than the industry average as 74.55% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 22.72
EV/EBITDA 16.81
MYRG Per share dataMYRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MYRG's earnings are expected to grow with 76.65% in the coming years.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y121.01%
EPS Next 3Y76.65%

0

5. Dividend

5.1 Amount

MYRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MYR GROUP INC/DELAWARE

NASDAQ:MYRG (12/5/2025, 8:00:01 PM)

After market: 228.54 0 (0%)

228.54

-1.69 (-0.73%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners103.86%
Inst Owner Change0.9%
Ins Owners1.52%
Ins Owner Change-0.4%
Market Cap3.55B
Revenue(TTM)3.51B
Net Income(TTM)97.82M
Analysts81.67
Price Target245.41 (7.38%)
Short Float %4.42%
Short Ratio2.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)4.94%
Max EPS beat(2)9.94%
EPS beat(4)4
Avg EPS beat(4)18.17%
Min EPS beat(4)4.94%
Max EPS beat(4)39.15%
EPS beat(8)5
Avg EPS beat(8)-4.25%
EPS beat(12)8
Avg EPS beat(12)2.79%
EPS beat(16)10
Avg EPS beat(16)2.33%
Revenue beat(2)2
Avg Revenue beat(2)3.19%
Min Revenue beat(2)0.82%
Max Revenue beat(2)5.55%
Revenue beat(4)3
Avg Revenue beat(4)0.53%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)5.55%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)8
Avg Revenue beat(12)3.32%
Revenue beat(16)12
Avg Revenue beat(16)3.36%
PT rev (1m)11.22%
PT rev (3m)14.3%
EPS NQ rev (1m)6.24%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)1.13%
EPS NY rev (3m)0.98%
Revenue NQ rev (1m)1.4%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)0.66%
Revenue NY rev (3m)0.47%
Valuation
Industry RankSector Rank
PE 36.92
Fwd PE 25.29
P/S 1.01
P/FCF 22.72
P/OCF 15.23
P/B 5.74
P/tB 8.25
EV/EBITDA 16.81
EPS(TTM)6.19
EY2.71%
EPS(NY)9.04
Fwd EY3.95%
FCF(TTM)10.06
FCFY4.4%
OCF(TTM)15
OCFY6.56%
SpS226.43
BVpS39.79
TBVpS27.7
PEG (NY)0.13
PEG (5Y)N/A
Graham Number74.45
Profitability
Industry RankSector Rank
ROA 5.95%
ROE 15.84%
ROCE 17.19%
ROIC 11.85%
ROICexc 13.03%
ROICexgc 17.24%
OM 4.13%
PM (TTM) 2.78%
GM 11.34%
FCFM 4.44%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
ROICexc(3y)8.68%
ROICexc(5y)10.33%
ROICexgc(3y)11.86%
ROICexgc(5y)13.66%
ROCE(3y)12.04%
ROCE(5y)13.96%
ROICexgc growth 3Y-34.99%
ROICexgc growth 5Y-7.87%
ROICexc growth 3Y-35.45%
ROICexc growth 5Y-8.52%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
F-Score7
Asset Turnover2.14
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.48
Debt/EBITDA 0.33
Cap/Depr 116.91%
Cap/Sales 2.18%
Interest Coverage 250
Cash Conversion 110.44%
Profit Quality 159.56%
Current Ratio 1.33
Quick Ratio 1.33
Altman-Z 5.09
F-Score7
WACC10.13%
ROIC/WACC1.17
Cap/Depr(3y)130.75%
Cap/Depr(5y)120.21%
Cap/Sales(3y)2.38%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)170.31%
EPS 3Y-28.02%
EPS 5Y-3.84%
EPS Q2Q%215.38%
EPS Next Y287.83%
EPS Next 2Y121.01%
EPS Next 3Y76.65%
EPS Next 5Y57.07%
Revenue 1Y (TTM)-0.64%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%7.02%
Revenue Next Year4.73%
Revenue Next 2Y7.17%
Revenue Next 3Y7.11%
Revenue Next 5Y7.77%
EBIT growth 1Y161.78%
EBIT growth 3Y-25.77%
EBIT growth 5Y-2.54%
EBIT Next Year402.31%
EBIT Next 3Y86.57%
EBIT Next 5Y63.85%
FCF growth 1Y423.34%
FCF growth 3Y-49.12%
FCF growth 5Y9.5%
OCF growth 1Y90.63%
OCF growth 3Y-14.06%
OCF growth 5Y6.06%

MYR GROUP INC/DELAWARE / MYRG FAQ

What is the fundamental rating for MYRG stock?

ChartMill assigns a fundamental rating of 5 / 10 to MYRG.


What is the valuation status of MYR GROUP INC/DELAWARE (MYRG) stock?

ChartMill assigns a valuation rating of 5 / 10 to MYR GROUP INC/DELAWARE (MYRG). This can be considered as Fairly Valued.


Can you provide the profitability details for MYR GROUP INC/DELAWARE?

MYR GROUP INC/DELAWARE (MYRG) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for MYRG stock?

The Price/Earnings (PE) ratio for MYR GROUP INC/DELAWARE (MYRG) is 36.92 and the Price/Book (PB) ratio is 5.74.